Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Antidepressant-mGlu2/3 receptor agonist combination may improve depression

Jan. 25, 2008

FDA accepts NovaDel's NDA for ZolpiMist oral spray in the treatment of insomnia

Jan. 24, 2008

Johnson & Johnson submits NDA in U.S. for immediate release tapentadol

Jan. 24, 2008

FDA places clinical hold on CytRx's phase IIb clinical trial of arimoclomol for ALS

Jan. 24, 2008

Serenex and CHDI enter agreement to evaluate Hsp90 inhibitors for Huntington's disease

Jan. 23, 2008

StemCells reports death of patient in phase I clinical trial of HuCNS-SC for NCL

Jan. 23, 2008

Novel SMN2 promoter activator by deCODE may be useful in SMA

Jan. 23, 2008

Positive clinical trial results for epilepsy drug rufinamide in mood disorders

Jan. 23, 2008

Novel analgesic agents imparted in recent Vertex and Merck Frosst patents

Jan. 23, 2008

Studies find little benefit of add-on lamotrigine in refractory schizophrenia patients

Jan. 23, 2008

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...